Methods for diagnosing high-risk cancer using polysialic acid and one or more tissue-specific biomarkers
US11448650B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2018 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Oct 21, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Described herein are methods for diagnosing high-risk cancer in a subject by detecting PolySialic Acid (polySia) in a biological sample obtained from the subject, or by detecting polySia and one or more tissue-specific markers in a biological sample obtained from the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.